Sergei B.; Pavel D.; Aigul G.; Firyuza B.; Ilmira N.; Ilshat M.; Aida A.; Refat K.; Natalia A.; Elena S.; Vera G.
(2020)
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. Deregulation of receptor tyrosine kinase (RTK)-signaling is frequently observed in many human malignancies, making activated RTKs the promising therapeutic targets. ...